research use only
Cat.No.S2298
| Related Targets | HDAC JAK BET Histone Methyltransferase PKC PARP HIF PRMT EZH2 AMPK |
|---|---|
| Other Sirtuin Inhibitors | SRT1720 HCl Selisistat (EX-527) Sirtinol 3-TYP AGK2 SRT2104 (GSK2245840) OSS_128167 SirReal2 SRT2183 Thiomyristoyl |
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|---|---|---|---|---|---|
| MDA-MB-453 | Cell viability assay | 0, 20, 40, 60, 80, and 100 µM | 24, 48, and 72 hours | With increasing concentrations of fisetin (0, 20, 40, 60, 80, and 100 µM), there was a decrease observed in cell number in different time intervals (24, 48, and 72 hours). | ||
| SGC7901 | Proliferation assay | 0, 1, 5, 10, 15 or 20 µM | 48 h | inhibits proliferation | ||
| A549 | Cell viability assay | 0, 10, 20, 30 or 40 µM | 24, 48 or 72 h | fisetin was effective in inhibiting the growth of A549 cells in a dose- and time-dependent manner | ||
| ARPE-19 | Cell migration assay | 5 or 10 μM | 24 h | pretreatment with fisetin markedly reduced cell migration in EGF-treated ARPE-19 cells | ||
| SCC-23 | Cell viability assay | 0-100 μM | 24 h | fisetin significantly inhibited cell viability in a dose-dependent manner (significantly when the concentration is higher than 20 μM) | ||
| Tca-8113 | Cell viability assay | 0-100 μM | 24 h | fisetin significantly inhibited cell viability in a dose-dependent manner (significantly when the concentration is higher than 20 μM) | ||
| Click to View More Cell Line Experimental Data | ||||||
|
In vitro |
DMSO
: 57 mg/mL
(199.13 mM)
Ethanol : 9 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 286.24 | Formula | C15H10O6 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 528-48-3 | Download SDF | Storage of Stock Solutions |
|
|
| Targets/IC50/Ki |
Sirtuin
|
|---|---|
| In vitro |
Fisetin selectively kills SPiDER-β-Gal positive senescence neural cells in vitro. |
| In vivo |
Oral administration of fisetin, a senolytic drug, reduces the number of senescent neural cells observed, the SASP expression level, and depressive behavior in MRL/lpr mice. |
References |
|
| Methods | Biomarkers | Images | PMID |
|---|---|---|---|
| Western blot | p-IKKα/β / IKKβ / IKKα / p-IκBα / IκBα / p-p65 / p65 XBP1s / ATF6 / CHOP / ATF4 / PERK DR3 / pNF-κB / NF-κB p-mTOR / mTOR / Raptor / Rictor |
|
23861901 |
| Immunofluorescence | p-4EBP1 / p-eIF4B / p-rpS6 uPA |
|
20530556 |
| Growth inhibition assay | Cell viability |
|
19670328 |
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT05758246 | Recruiting | Sepsis|Acute Infection|Organ Failure |
University of Minnesota |
August 23 2023 | Phase 2 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.